Published in J Exp Med on June 05, 2000
CD8 epitope escape and reversion in acute HCV infection. J Exp Med (2004) 2.77
Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. J Virol (2004) 2.71
Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother (2005) 2.32
Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc Natl Acad Sci U S A (2003) 2.13
Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J Virol (2002) 1.63
Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses. J Virol (2005) 1.28
Immunity to seasonal and pandemic influenza A viruses. Microbes Infect (2011) 1.21
A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol (2004) 1.17
Escape mutations alter proteasome processing of major histocompatibility complex class I-restricted epitopes in persistent hepatitis C virus infection. J Virol (2005) 1.15
Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc Natl Acad Sci U S A (2010) 1.13
Aryl hydrocarbon receptor activation reduces dendritic cell function during influenza virus infection. Toxicol Sci (2010) 1.11
Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice. PLoS One (2011) 1.06
Evasion of influenza A viruses from innate and adaptive immune responses. Viruses (2012) 1.06
Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. J Virol (2003) 1.03
Complete modification of TCR specificity and repertoire selection does not perturb a CD8+ T cell immunodominance hierarchy. Proc Natl Acad Sci U S A (2008) 0.95
Multipronged CD4(+) T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus. Immunol Rev (2013) 0.93
Perforin and Fas cytolytic pathways coordinately shape the selection and diversity of CD8+-T-cell escape variants of influenza virus. J Virol (2005) 0.90
Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages. J Virol (2015) 0.88
Antibody-mediated protection against cytotoxic T-cell escape in coronavirus-induced demyelination. J Virol (2003) 0.87
The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro. Clin Exp Immunol (2007) 0.85
Preemptive priming readily overcomes structure-based mechanisms of virus escape. Proc Natl Acad Sci U S A (2013) 0.84
Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC. J Exp Med (2013) 0.83
Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful. Arch Immunol Ther Exp (Warsz) (2013) 0.83
Prevention of cytotoxic T cell escape using a heteroclitic subdominant viral T cell determinant. PLoS Pathog (2008) 0.82
Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma. Hepatology (2014) 0.80
Cross-reactivity of T cells and its role in the immune system. Crit Rev Immunol (2012) 0.80
Protective efficacy of a DNA influenza virus vaccine is markedly increased by the coadministration of a Schiff base-forming drug. J Virol (2004) 0.80
Cross-protective immune responses elicited by live attenuated influenza vaccines. Yonsei Med J (2013) 0.79
Multiple distinct forms of CD8+ T cell cross-reactivity and specificities revealed after 2009 H1N1 influenza A virus infection in mice. PLoS One (2012) 0.79
Antiviral antibodies are necessary to prevent cytotoxic T-lymphocyte escape in mice infected with a coronavirus. J Virol (2007) 0.78
Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice. J Gen Virol (2013) 0.77
Influenza A virus-specific CD8 T-cell responses: from induction to function. Future Virol (2010) 0.77
Pathogenic potential of borna disease virus lacking the immunodominant CD8 T-cell epitope. J Virol (2007) 0.75
Long-term adaptation of the influenza A virus by escaping cytotoxic T-cell recognition. Sci Rep (2016) 0.75
Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity (1998) 17.27
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
USE OF MOVING AVERAGES AND INTERPOLATION TO ESTIMATE MEDIAN-EFFECTIVE DOSE: I. Fundamental Formulas, Estimation of Error, and Relation to Other Methods. Bacteriol Rev (1947) 11.32
Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology (1968) 11.20
Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol (1989) 8.84
In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med (1984) 6.27
Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity (1998) 5.98
Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1985) 5.42
Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature (1990) 5.41
Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology (1999) 5.07
Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol (1992) 4.83
Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med (1995) 4.65
Viral strategies of immune evasion. Science (1998) 4.48
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (1994) 4.42
CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol (1997) 4.10
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature (1994) 3.97
Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature (1979) 3.91
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev (1997) 3.88
Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature (1998) 3.78
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell (1990) 3.44
Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol Rev (1997) 3.20
Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev (1994) 3.00
The immune response to influenza infection. Curr Top Microbiol Immunol (1986) 2.83
The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells. J Exp Med (1984) 2.81
Variation of influenza A, B, and C viruses. Science (1982) 2.75
Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med (1997) 2.67
Making the T cell receptor go the distance: a topological view of T cell activation. Immunity (1997) 2.63
Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med (1998) 2.31
Evolutionary processes in influenza viruses: divergence, rapid evolution, and stasis. Curr Top Microbiol Immunol (1992) 2.09
Vaccinia virus immune evasion. Immunol Rev (1997) 2.03
Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature (1992) 2.01
The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection. Cell (1994) 1.90
Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen. Dev Immunol (1993) 1.87
Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med (1997) 1.73
Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. J Immunol (1996) 1.61
Selective expansion of cross-reactive CD8(+) memory T cells by viral variants. J Exp Med (1999) 1.58
Subversion of the immune system by pathogens. Cell (1994) 1.53
Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. Proc Natl Acad Sci U S A (1992) 1.52
T cell responses and viral escape. Cell (1998) 1.52
Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine. J Virol (1998) 1.47
Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol (1991) 1.47
Cytotoxic T lymphocytes specific for influenza virus. Curr Top Microbiol Immunol (1994) 1.43
Interference with antigen processing by viruses. Curr Opin Immunol (1997) 1.40
Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity (1996) 1.29
Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo? Immunol Rev (1998) 1.17
CTL escape viral variants. II. Biologic activity in vivo. Virology (1995) 1.15
Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli. Proc Natl Acad Sci U S A (1993) 1.13
New strategies of immune modulation by DNA viruses. Transplant Proc (1996) 1.12
Functional commitment to helper T cell lineage precedes positive selection and is independent of T cell receptor MHC specificity. Immunity (1994) 1.05
Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes. Eur J Immunol (1999) 0.93
Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes. Proc Natl Acad Sci U S A (1998) 0.93
Inhibition of thymocyte negative selection by T cell receptor antagonist peptides. Eur J Immunol (1996) 0.92
Regulation of antigen processing and presentation to class I MHC restricted CD8+ T lymphocytes. Immunol Rev (1996) 0.83
Object-related activity revealed by functional magnetic resonance imaging in human occipital cortex. Proc Natl Acad Sci U S A (1995) 5.98
Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature (1990) 5.41
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett (1990) 5.14
Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science (2000) 4.61
Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol (1994) 4.34
Electron transfer by domain movement in cytochrome bc1. Nature (1998) 4.08
Immune pathways and defence mechanisms in honey bees Apis mellifera. Insect Mol Biol (2006) 3.98
Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst (1997) 3.92
High-level semi-synthetic production of the potent antimalarial artemisinin. Nature (2013) 3.80
Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac. Nat Genet (2001) 3.65
Ethical consideration of incidental findings on adult brain MRI in research. Neurology (2004) 3.56
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A (2000) 3.44
Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat Genet (1998) 3.24
Alterations of the PPP2R1B gene in human lung and colon cancer. Science (1998) 3.14
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet (1996) 3.02
Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood (2001) 3.00
Airtraq laryngoscope versus conventional Macintosh laryngoscope: a systematic review and meta-analysis. Anaesthesia (2011) 2.83
Gene therapy progress and prospects: nonviral vectors. Gene Ther (2002) 2.79
Targeted inactivation of the sodium-calcium exchanger (Ncx1) results in the lack of a heartbeat and abnormal myofibrillar organization. FASEB J (2001) 2.78
A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun (1991) 2.72
Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J Virol (2001) 2.69
Toxicity of ALS-linked SOD1 mutants. Science (2000) 2.69
Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis (2009) 2.68
Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther (2001) 2.67
Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature (1991) 2.66
Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility. Med Phys (2004) 2.64
First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol (2001) 2.44
The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med (1990) 2.40
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A (1993) 2.35
Hormone-stimulated polyphosphoinositide breakdown in rat liver plasma membranes. Roles of guanine nucleotides and calcium. J Biol Chem (1986) 2.32
Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol (1998) 2.28
DMC1 functions in a Saccharomyces cerevisiae meiotic pathway that is largely independent of the RAD51 pathway. Genetics (1997) 2.26
A two-year randomized clinical trial of chlorhexidine varnish on dental caries in Chinese preschool children. J Dent Res (2006) 2.22
Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology (1999) 2.20
Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection (2013) 2.18
Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes. J Virol (1996) 2.17
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst (1998) 2.16
The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis. Genes Dev (2001) 2.15
ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol (2001) 2.14
Enzymatic completion of mammalian lagging-strand DNA replication. Proc Natl Acad Sci U S A (1994) 2.11
The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta (1995) 2.10
Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J Immunol (1993) 2.10
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Proteomic analysis of nucleoporin interacting proteins. J Biol Chem (2001) 2.06
Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol Carcinog (1998) 2.06
A novel gene causing a mendelian audiogenic mouse epilepsy. Neuron (2001) 2.05
Polymorphisms in the taste receptor gene (Tas1r3) region are associated with saccharin preference in 30 mouse strains. J Neurosci (2004) 2.03
Transmembrane pH gradient and membrane potential in Clostridium acetobutylicum during growth under acetogenic and solventogenic conditions. Appl Environ Microbiol (1985) 2.02
Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta (1991) 2.01
Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol (1994) 2.00
Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.98
Estimating cancer risk in relation to tritium exposure from routine operation of a nuclear-generating station in Pickering, Ontario. Chronic Dis Inj Can (2013) 1.97
Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene (2007) 1.95
Crystal structure of an activated response regulator bound to its target. Nat Struct Biol (2001) 1.95
Spatially varying optical property reconstruction using a finite element diffusion equation approximation. Med Phys (1995) 1.92
Regulation of F-actin binding to platelet moesin in vitro by both phosphorylation of threonine 558 and polyphosphatidylinositides. Mol Biol Cell (1999) 1.91
New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett (1994) 1.90
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88
Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol (2000) 1.86
Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. J Immunol (1985) 1.86
Benchmark data and power calculations for evaluating disease outbreak detection methods. MMWR Morb Mortal Wkly Rep (2004) 1.86
Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther (1997) 1.86
Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther (2006) 1.84
Patterns of protein synthesis and tolerance of anoxia in root tips of maize seedlings acclimated to a low-oxygen environment, and identification of proteins by mass spectrometry. Plant Physiol (2000) 1.82
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest (2000) 1.82
Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann Neurol (2000) 1.82
The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol (2000) 1.81
The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther (1999) 1.81
Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst (1998) 1.81
Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta (1994) 1.79
A physical map of chromosome 2 of Arabidopsis thaliana. Genome Res (1996) 1.77
Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther (2001) 1.76
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol (2001) 1.73
A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol (2000) 1.71
Broad-spectrum, transmissible beta-lactamases. N Engl J Med (1988) 1.70
Two cortical areas mediate multisensory integration in superior colliculus neurons. J Neurophysiol (2001) 1.68
Cationic liposome-mediated gene transfer. Gene Ther (1995) 1.68
Nonviral gene therapy: promises and challenges. Gene Ther (2000) 1.65
Recovery from acute virus infection. Role of cytotoxic T lymphocytes in the elimination of lymphocytic choriomeningitis virus from spleens of mice. Ann N Y Acad Sci (1988) 1.62
Identification of MECL-1 (LMP-10) as the third IFN-gamma-inducible proteasome subunit. J Immunol (1996) 1.62
China at the crossroads: the economics of tobacco and health. Tob Control (2006) 1.62
Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol Rev (1993) 1.61
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther (2008) 1.61
Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol (1999) 1.61
Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res (2000) 1.60
Frequency-domain fluorescent diffusion tomography: a finite-element-based algorithm and simulations. Appl Opt (1998) 1.60
Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry (1996) 1.60
The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge. J Virol (1998) 1.57
Structure and function of lipid-DNA complexes for gene delivery. Annu Rev Biophys Biomol Struct (2000) 1.57
Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (2000) 1.56
Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem (1996) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Structural and antigenic analysis of a truncated form of the herpes simplex virus glycoprotein gH-gL complex. J Virol (1998) 1.54
Substrate specificity of naphthalene dioxygenase: effect of specific amino acids at the active site of the enzyme. J Bacteriol (2000) 1.54
Architectural design and tools to support the transparent access to hospital information systems, radiology information systems, and picture archiving and communication systems. J Digit Imaging (1996) 1.54
In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1991) 1.54